ORIGINAL ARTICLE |
|
Year : 2018 | Volume
: 11
| Issue : 1 | Page : 48-52 |
|
Effects of aqueous extract of Notobasis syriaca on lipopolysaccharide-induced inflammation in rats
Abdullatif Azab1, Ahmad Nassar2, Jacob Kaplanski2, Reem Mahajneh2, Galila Agam2, Abed N Azab Ph.D. 3
1 Triangle Research & Development Center, Kfar-Qari, 30026 ; Formerly: Institute of applied Research, Box 437, Shefa-Amr, 20200, Israel 2 Department of Clinical Biochemistry and Pharmacology, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel 3 Department of Clinical Biochemistry and Pharmacology, Faculty of Health Sciences; Department of Nursing, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel
Correspondence Address:
Abed N Azab School for Community Health Professions, Faculty of Health Sciences, Ben-Gurion University of the Negev, P.O.B 653, Beer-Sheva 84105 Israel
 Source of Support: None, Conflict of Interest: None  | 2 |
DOI: 10.4103/1995-7645.223533
|
|
Objective: To investigate the effects of a dry aqueous extract of Notobasis syriaca (N. syriaca) on lipopolysaccharide (LPS)-induced inflammation in rats. Methods: Rats were fed the dried extract [500 mg/(kgod)] for three consecutive days and then were intraperitoneally injected with LPS (1 mg/kg). Two hours after LPS injection, rats were sacrificed and blood and brain regions were collected. Inflammatory mediators’ levels in plasma and homogenates of brain regions were determined by ELISA. Results: Pretreatment with the N. syriaca extract resulted in significant anti-inflammatory effects (P<0.05), including: i) attenuated LPS-induced hypothermia; ii) decreased hypothalamus and hippocampus prostaglandin E2 levels in the LPS- treated rats; and, iii) reduced hypothalamus and hippocampus interleukin-6 and tumor necrosis factor- α levels in the LPS-treated rats. Conclusions: These results suggest that N. syriaca possesses anti-inflammatory properties. Thus, it is possible that long-term consumption of this plant may result in beneficial pharmacological effects.
|
|
|
|
[FULL TEXT] [PDF]* |
|
 |
|